Foundation for Sarcoidosis Research Welcomes Three New Members to its Board of Directors
/PRNewswire/ — The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and…
/PRNewswire/ — The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and…
/PRNewswire/ — Ro, the leading direct-to-patient healthcare company, today introduced the Ro Operating System (ro.OS) – its technology platform delivering…
/PRNewswire/ — NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing novel treatments for severe neurodegenerative diseases,…
/PRNewswire/ — Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved the high-concentration, citrate-free…
Study examines if gene editing can help people living with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) WASHINGTON, May 2, 2024 /PRNewswire/ — The…
/PRNewswire/ — Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered…
Dismantling Medical School Diversity, Equity, and Inclusion Efforts Threaten to Increase Physician-Patient Gap: Largest Study of U.S. Underrepresented Medical School Students Reveals Urgent Concerns. Washington,…
Xavier University of Louisiana and Ochsner Health signed a deal to create fifth HBCU medical school in the U.S.
/PRNewswire/ — With every successive year, the lines between medical devices and consumer electronics become increasingly blurred – medtech companies seek to…
President, National Medical Association The Biden Administration, today, declared that it is delaying the proposed plan to ban menthol cigarettes. Menthol cigarettes have been proven,…
New Haven, Conn. — Yale School of Medicine and Equitable Breakthroughs in Medicine Development (EQBMED) — a multi-institute collaboration focused on clinical trial diversity —…